These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9526553)

  • 1. Acetamidine lysine derivative, N-(5(S)-amino-6,7-dihydroxyheptyl)ethanimidamide dihydrochloride: a highly selective inhibitor of human inducible nitric oxide synthase.
    Hallinan EA; Tsymbalov S; Finnegan PM; Moore WM; Jerome GM; Currie MG; Pitzele BS
    J Med Chem; 1998 Mar; 41(6):775-7. PubMed ID: 9526553
    [No Abstract]   [Full Text] [Related]  

  • 2. 2-Iminopyrrolidines as potent and selective inhibitors of human inducible nitric oxide synthase.
    Hagen TJ; Bergmanis AA; Kramer SW; Fok KF; Schmelzer AE; Pitzele BS; Swenton L; Jerome GM; Kornmeier CM; Moore WM; Branson LF; Connor JR; Manning PT; Currie MG; Hallinan EA
    J Med Chem; 1998 Sep; 41(19):3675-83. PubMed ID: 9733492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-Iminohomopiperidinium salts as selective inhibitors of inducible nitric oxide synthase (iNOS).
    Hansen DW; Peterson KB; Trivedi M; Kramer SW; Webber RK; Tjoeng FS; Moore WM; Jerome GM; Kornmeier CM; Manning PT; Connor JR; Misko TP; Currie MG; Pitzele BS
    J Med Chem; 1998 Apr; 41(9):1361-6. PubMed ID: 9554868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3-Hydroxy-4-methyl-5-pentyl-2-iminopyrrolidine: a potent and highly selective inducible nitric oxide synthase inhibitor.
    Tsymbalov S; Hagen TJ; Moore WM; Jerome GM; Connor JR; Manning PT; Pitzele BS; Hallinan EA
    Bioorg Med Chem Lett; 2002 Nov; 12(22):3337-9. PubMed ID: 12392746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural requirements for human inducible nitric oxide synthase substrates and substrate analogue inhibitors.
    Grant SK; Green BG; Stiffey-Wilusz J; Durette PL; Shah SK; Kozarich JW
    Biochemistry; 1998 Mar; 37(12):4174-80. PubMed ID: 9521739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aromatic reduced amide bond peptidomimetics as selective inhibitors of neuronal nitric oxide synthase.
    Hah JM; Martásek P; Roman LJ; Silverman RB
    J Med Chem; 2003 Apr; 46(9):1661-9. PubMed ID: 12699384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substituted 2-iminopiperidines as inhibitors of human nitric oxide synthase isoforms.
    Webber RK; Metz S; Moore WM; Connor JR; Currie MG; Fok KF; Hagen TJ; Hansen DW; Jerome GM; Manning PT; Pitzele BS; Toth MV; Trivedi M; Zupec ME; Tjoeng FS
    J Med Chem; 1998 Jan; 41(1):96-101. PubMed ID: 9438025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-Phenylamidines as selective inhibitors of human neuronal nitric oxide synthase: structure-activity studies and demonstration of in vivo activity.
    Collins JL; Shearer BG; Oplinger JA; Lee S; Garvey EP; Salter M; Duffy C; Burnette TC; Furfine ES
    J Med Chem; 1998 Jul; 41(15):2858-71. PubMed ID: 9667974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of pyrrolidin-2-imines and 1,3-thiazolidin-2-imines as inhibitors of nitric oxide synthase.
    Shankaran K; Donnelly KL; Shah SK; Guthikonda RN; MacCoss M; Humes JL; Pacholok SG; Grant SK; Kelly TM; Wong KK
    Bioorg Med Chem Lett; 2004 Sep; 14(17):4539-44. PubMed ID: 15357988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of inducible nitric oxide synthase in cultured smooth muscle cells from rat mesenteric lymphatic vessels.
    Robertson DA; Hughes GA; Lyles GA
    Microcirculation; 2004 Sep; 11(6):503-15. PubMed ID: 15371131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and synthesis of orally bioavailable inhibitors of inducible nitric oxide synthase. Identification of 2-azabicyclo[4.1.0]heptan-3-imines.
    Kawanaka Y; Kobayashi K; Kusuda S; Tatsumi T; Murota M; Nishiyama T; Hisaichi K; Fujii A; Hirai K; Naka M; Komeno M; Odagaki Y; Nakai H; Toda M
    Bioorg Med Chem; 2003 Apr; 11(8):1723-43. PubMed ID: 12659759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1,2-Dihydro-4-quinazolinamines: potent, highly selective inhibitors of inducible nitric oxide synthase which show antiinflammatory activity in vivo.
    Tinker AC; Beaton HG; Boughton-Smith N; Cook TR; Cooper SL; Fraser-Rae L; Hallam K; Hamley P; McInally T; Nicholls DJ; Pimm AD; Wallace AV
    J Med Chem; 2003 Mar; 46(6):913-6. PubMed ID: 12620067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of acute experimental colitis by a highly selective inducible nitric-oxide synthase inhibitor, N-[3-(aminomethyl)benzyl]acetamidine.
    Kankuri E; Vaali K; Knowles RG; Lähde M; Korpela R; Vapaatalo H; Moilanen E
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1128-32. PubMed ID: 11504810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of orally bioavailable inhibitors of inducible nitric oxide synthase. Part 1: synthesis and biological evaluation of dihydropyridin-2-imines.
    Kawanaka Y; Kobayashi K; Kusuda S; Tatsumi T; Murota M; Nishiyama T; Hisaichi K; Fujii A; Hirai K; Naka M; Komeno M; Nakai H; Toda M
    Bioorg Med Chem Lett; 2002 Sep; 12(17):2291-4. PubMed ID: 12161118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of orally bioavailable inhibitors of inducible nitric oxide synthase. synthesis and biological evaluation of dihydropyridin-2(1H)-imines and 1,5,6,7-tetrahydro-2H-azepin-2-imines.
    Kawanaka Y; Kobayashi K; Kusuda S; Tatsumi T; Murota M; Nishiyama T; Hisaichi K; Fujii A; Hirai K; Nishizaki M; Naka M; Komeno M; Nakai H; Toda M
    Bioorg Med Chem; 2003 Mar; 11(5):689-702. PubMed ID: 12537998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformationally constrained NO synthase inhibitors: rigid analogs of L-N-iminoethylornithine.
    Eustache J; Grob A; Lam C; Sellier O; Schulz G
    Bioorg Med Chem Lett; 1998 Nov; 8(21):2961-6. PubMed ID: 9873655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of inhibitors of inducible nitric oxide synthase from microbial extracts.
    Alvi KA; Baker DD; Stienecker V; Hosken M; Nair BG
    J Antibiot (Tokyo); 2000 May; 53(5):496-501. PubMed ID: 10908113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel and orally bioavailable inducible nitric oxide synthase inhibitors: synthesis and evaluation of optically active 4,5-dialkyl-2-iminoselenazolidine derivatives.
    Ueda S; Terauchi H; Suzuki K; Yano A; Matsumoto M; Kubo T; Minato H; Arai Y; Tsuji J; Watanabe N
    Bioorg Med Chem Lett; 2005 Mar; 15(5):1361-6. PubMed ID: 15713387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of inducible nitric oxide synthase by acetamidine derivatives of hetero-substituted lysine and homolysine.
    Young RJ; Beams RM; Carter K; Clark HA; Coe DM; Chambers CL; Davies PI; Dawson J; Drysdale MJ; Franzman KW; French C; Hodgson ST; Hodson HF; Kleanthous S; Rider P; Sanders D; Sawyer DA; Scott KJ; Shearer BG; Stocker R; Smith S; Tackley MC; Knowles RG
    Bioorg Med Chem Lett; 2000 Mar; 10(6):597-600. PubMed ID: 10741561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of selective and non-selective inhibition of nitric oxide synthase on the expression and activity of cyclooxygenase-2 during gastric ulcer healing.
    Guo JS; Cho CH; Wang JY; Koo MW
    Eur J Pharmacol; 2006 May; 536(3):301-8. PubMed ID: 16600210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.